Skip to content
SHORLA ONCOLOGY
  • About Us
  • Our Team
    • Executive Team
    • Leadership Team
    • Board of Directors
    • Advisory Team
  • Products
    • SH-105
    • SH-110
    • SH-111
    • SH-114
  • Careers
  • News
    • Company Updates
    • Media
  • Contact

Company Updates

Shorla Oncology at Asembia Specialty Pharmacy Summit

March 7th 2022October 22nd 2021

Read More

Shorla recently welcomed the Minister of State for Business, Employment and Retail, Damien English to the Clonmel office

March 7th 2022September 24th 2021

Read More

Shorla Oncology at HLTH Boston 2021

March 7th 2022September 24th 2021

Read More

Shorla Oncology at Biotech Week Boston

March 7th 2022September 17th 2021

Read More

Reuters Global Pharma Awards – Finalist

March 7th 2022September 13th 2021

Read More

Shorla Oncology Announces Partnership with EVERSANA

March 7th 2022August 17th 2021

Read More

Shorla Oncology Expands into the U.S.

March 7th 2022July 14th 2021

Read More

Team Shorla Oncology complete 100k in 30 days for Breast Cancer

March 7th 2022June 30th 2021

Read More

FDA filing acceptance and priority review received for SH-111

March 7th 2022April 23rd 2021

Read More

Post navigation
Older posts
Newer posts
Page1 Page2 Page3 … Page6

IRELAND HQ:
Questum Acceleration Center,
Ballingarrane Science & Technology Park,
Clonmel, Co. Tipperary,
E91 V329, Ireland

Shorla Pharma Ltd trading as Shorla Oncology

 

US OFFICE:
245 Main St.,
2nd floor,
Cambridge,
MA 02142, USA

SITEMAP
PRIVACY POLICY
Company number: 618033

©SHORLA ONCOLOGY 2022
© 2022 SHORLA ONCOLOGY • Built with GeneratePress
  • About Us
  • Our Team
    • Executive Team
    • Leadership Team
    • Board of Directors
    • Advisory Team
  • Products
    • SH-105
    • SH-110
    • SH-111
    • SH-114
  • Careers
  • News
    • Company Updates
    • Media
  • Contact